Cargando…
Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence
The senescence‐associated secretory phenotype (SASP) is a striking characteristic of senescence. Accumulation of SASP factors causes a pro‐inflammatory response linked to chronic disease. Suppressing senescence and SASP represents a strategy to prevent or control senescence‐associated diseases. Here...
Autores principales: | Gao, Li‐Bin, Wang, Ya‐Hong, Liu, Zhi‐Hua, Sun, Yu, Cai, Peng, Jing, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520720/ https://www.ncbi.nlm.nih.gov/pubmed/34587364 http://dx.doi.org/10.1111/acel.13483 |
Ejemplares similares
-
In Vitro Metabolic Studies of REV-ERB Agonists SR9009 and SR9011
por: Geldof, Lore, et al.
Publicado: (2016) -
SR9009 Regulates Acute Lung Injury in Mice Induced by Sepsis
por: Hu, Ming, et al.
Publicado: (2022) -
Rev-erbα agonist SR9009 protects against cerebral ischemic injury through mechanisms involving Nrf2 pathway
por: Sheng, Mingyue, et al.
Publicado: (2023) -
REV-ERBα Agonist SR9009 Promotes a Negative Energy Balance in Goldfish
por: Saiz, Nuria, et al.
Publicado: (2022) -
SR9009 improves heart function after pressure overload independent of cardiac REV-ERB
por: Li, Hui, et al.
Publicado: (2022)